BP1003 - Bio-path
liposomal Bcl2 (BP-100-1.02) - Bio-path
Venclexta (venetoclax) - Roche, AbbVie
prexigebersen (BP1001) - Bio-path
decitabine - Generic mfg.
http://www.globenewswire.com/news-release/2019/11/15/1947924/0/en/Bio-Path-Holdings-Reports-Third-Quarter-2019-Financial-Results.html
 
Nov 15, 2019
 
Prev Next